Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8777 |
High Similarity |
NPD7266 |
Discontinued |
0.8667 |
High Similarity |
NPD3027 |
Phase 3 |
0.8613 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8613 |
High Similarity |
NPD1613 |
Approved |
0.8435 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8392 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8346 |
Intermediate Similarity |
NPD1091 |
Approved |
0.8321 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8248 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8228 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8176 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8176 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8074 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7985 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7963 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7937 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7923 |
Intermediate Similarity |
NPD228 |
Approved |
0.7914 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7901 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7852 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7834 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7805 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7742 |
Intermediate Similarity |
NPD37 |
Approved |
0.7742 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7727 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7708 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7707 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7707 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7698 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7692 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7687 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7682 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7671 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7671 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7671 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7669 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7658 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7595 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7593 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7554 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD5588 |
Approved |
0.75 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7466 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7455 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7432 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7426 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7425 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7425 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD3060 |
Approved |
0.74 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7397 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7379 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7353 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7348 |
Intermediate Similarity |
NPD290 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7303 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7303 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7297 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7292 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7286 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7286 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7286 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7286 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD968 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7261 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7261 |
Intermediate Similarity |
NPD3686 |
Approved |
0.726 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7255 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD5773 |
Approved |
0.725 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7248 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7231 |
Intermediate Similarity |
NPD291 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7205 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7197 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.719 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7171 |
Intermediate Similarity |
NPD5763 |
Approved |
0.717 |
Intermediate Similarity |
NPD4678 |
Approved |
0.717 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7162 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7133 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7111 |
Intermediate Similarity |
NPD556 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.708 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7069 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7069 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7069 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7039 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7033 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7025 |
Intermediate Similarity |
NPD52 |
Approved |
0.7025 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6987 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD5241 |
Discontinued |
0.6982 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6981 |
Remote Similarity |
NPD2122 |
Discontinued |
0.698 |
Remote Similarity |
NPD5718 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD7906 |
Approved |
0.6966 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6966 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD27 |
Approved |
0.6964 |
Remote Similarity |
NPD2489 |
Approved |
0.6962 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD3536 |
Discontinued |
0.6962 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6954 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6954 |
Remote Similarity |
NPD1933 |
Approved |
0.6954 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6946 |
Remote Similarity |
NPD6071 |
Discontinued |
0.6944 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6936 |
Remote Similarity |
NPD7312 |
Approved |
0.6936 |
Remote Similarity |
NPD7313 |
Approved |
0.6936 |
Remote Similarity |
NPD7311 |
Approved |
0.6936 |
Remote Similarity |
NPD7310 |
Approved |
0.6933 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD3179 |
Approved |
0.6913 |
Remote Similarity |
NPD3180 |
Approved |
0.6909 |
Remote Similarity |
NPD5604 |
Discontinued |
0.6908 |
Remote Similarity |
NPD3054 |
Approved |
0.6908
|
Remote Similarity |
NPD3052 |
Approved |